Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
Clinical trial NCT01797926 · COMPLETED
Trial details
- NCT number
- NCT01797926
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-23
- Primary completion
- 2013-07-25
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.